Exploring the Potential and Challenges of Cannabinoids for Pets: Insights from Robert Silver, DVM MS CVA
This interview discusses the challenges in conducting unbiased research on the benefits of minor cannabinoids for pets, the potential synergistic effects of terpenes, and emerging research on using cannabinoid blends to treat conditions like epilepsy in dogs.
As interest in cannabinoid-based therapies continues to grow, so too does interest in the effects of cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD) on pets such as dogs, cats, and horses.
For insights into veterinary uses for cannabinoids and pets, Madeline Colli, Editor of Cannabis Science and Technology, sat down with Robert Silver, DVM MS CVA, author of the book, Medical Marijuana and Your Pet and founder of the Well-Pet Dispensary. In the interview, Dr. Silver covers a variety of topics including dosing and administration of cannabinoids to animals, the effects on different species, potential adverse effects, federal laws, research, and more.
In this sneak peek, we cover potential benefits of minor cannabinoids for pets, the role of terpenes in pet products, and emerging research on cannabis and epilepsy.
Watch the video clip, read the transcript below, and stay tuned for more on cannabis and veterinarian medicine!
Madeline Colli: Is there any new and emerging research on pets and cannabinoids that has caught your eye recently?
Robert Silver:We have had a couple of decent studies in epilepsy. One study used that blend of CBD and CBDA, and at fairly reasonably low dosages of about a milligram per each of those, or twice daily. And they were able to get reasonably good success, better success than the other study that was done at CSU by McGrath, in terms of treating dogs who have what we call “treatment resistant epilepsy,” that's a very similar condition to what Charlotte Figi had, the child that got things started with Charlotte's Web and the whole interest in in CBD for these intractable epileptics. So that was good. And these are really very sad cases, because they could be on three different types of anti-convulsant drugs. They could be walking zombies, because many of these drugs create a sedation, and yet still have seizures. And the drugs are expensive, the dogs are miserable, so if we can find anything that can help with that… And that's good that they were able to do that.
I think that with dogs who are not having treatment resistant epilepsy, anecdotally, from what I have been talking to pet parents about, is that if they've got the seizures only occasionally, we feel that we don't really want to use drugs to treat seizures in a dog, because the drugs are so strong and potentially have their own downsides, unless the dog is having seizures frequently. And frequently would mean like weekly, really, if it's like once a month that's not frequent enough, maybe twice a month you start to get on the on the edge of making that decision. So for those dogs that are infrequent with their seizures and not very severe, and sometimes that's just the beginning, well maybe over time they may progress to be worse. We've seen good response to doses of CBD for these epileptics that are uncomplicated. When I treat an animal, I don't just use the CBD. I would, with an epileptic, I might use an herb, I might use a high dose of fish oil, because fish oil is a natural anti-inflammatory, and good for epilepsy, and had can gain high levels in the brain, so but just talking about cannabinoids, that's kind of what we find.
Inside the University of Maryland School of Pharmacy’s Graduate Program in Medical Cannabis
September 16th 2024Leah Sera, PharmD, MA, the co-program director for the University of Maryland School of Pharmacy’s Graduate Studies in Medical Cannabis program sat down with Cannabis Science and Technology to discuss higher education in medical cannabis.
Studying the Evolution of Cannabis Education: Insights from Stockton University’s Course Instructors
September 13th 2024A leader in cannabis education in New Jersey, Stockton University offers a wide variety of courses to prepare its students to not only succeed in an ever-growing industry, but to also understand its complex history and shape its evolving future. Started six years ago, its Cannabis Studies Program continues its commitment to providing innovative and practical instruction to its students. Two influential figures in this space are Robert Mejia, Teaching Specialist in the Cannabis Studies Program, and Angela Speakman, Instructor in the Cannabis Studies Program. Here, they highlight the program’s practical approach to cannabis education, celebrate the success stories of graduates, discuss the National Cannabis Curriculum Convening, and address challenges in cannabis education and its role in the future.
Medical Cannabis Campaigning with Americans for Safe Access
September 4th 2024As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.
Insights on Cannabis Testing Challenges and Industry Standards: An Interview with Douglas Duncan
August 9th 2024In light of recent headlines concerning cannabis laboratories throughout the country, Cannabis Science and Technology reached out to Douglas Duncan, Laboratory Director of Kairos Labs in Detroit, MI and member of our Editorial Advisory Board for more information. In this interview, Duncan shares his perspectives on lab shopping, major challenges in the industry today, and innovations in cannabis testing laboratories for the future. He also shares insights into consumer practices and the potential effects of a federal rescheduling of cannabis.
Patients on the Front Line: Nikki Lawley’s Insights on Medical Cannabis Today
June 25th 2024In the ongoing dialogue surrounding cannabis, the testimonials of medical cannabis patients stand as crucial reminders of its impacts and benefits in the industry. For a deep dive into this topic, Cannabis Science and Technology sat down with Nikki Lawley, founder of Nikki and the Plant, LLC, for her take on the challenges patients face today in the midst of discussions of industry developments such as the rescheduling of cannabis. A traumatic brain injury survivor, Lawley now actively supports medical cannabis access and engages diverse audiences through her journey as a pediatric nurse-turned-patient-and-advocate. Here, she explains the importance of educating people about cannabis, the need for patient perspective in cannabis policy decisions, and the benefits of empathetic approaches to medical cannabis use.
